No Data
No Data
Bristol Myers' (BMY) Krazati Gets FDA Nod for Colorectal Cancer
Bristol Myers (BMY) Gets FDA Nod for Label Expansion of Augtyro
AstraZeneca (AZN) Plans to Generate $80B in Revenues by 2030
Form 144 | Ligand Pharmaceuticals(LGND.US) Officer Proposes to Sell 446.84K in Common Stocks
SEC FILLINGS DISCLOSED/ May 17, $Ligand Pharmaceuticals(LGND.US)$、$LIGAND PHARMACEUTICAL INC(LGNDZ.US)$、$LIGAND PHARMACEUTICAL INC(LGNXZ.US)$、$LIGAND PHARMACEUTICAL INC(LGNYZ.US)$、$LIGAND PHARMACEUTIC
Eli Lilly's (LLY) Efsitora Matches Daily Insulins in A1C Control
Amgen's (AMGN) Tarlatamab Receives FDA Approval for SCLC
No Data